- Type of Event: Earnings Conference Call discussing the Un-audited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026 (Q1 FY27).
- Date and Time: The call was held on Tuesday, August 11, 2026. A specific time and time zone were not disclosed in the provided transcript.
- Purpose: The primary purpose was to discuss the company's Q1 FY27 financial performance and provide a business update, including segmental performance, outlook, and guidance.
- Earnings Announcement Timing: The call was held after the earnings announcement. The transcript refers to disclosures dated August 4, 2026, and August 11, 2026.
- Management Participants: The call was led by Mr. Ashish Dandekar (Chairman & Managing Director), Mr. Nirmal Momaya (Managing Director), and Mr. Santosh Parab (Chief Financial Officer).
- Availability of Materials: The transcript of the call was submitted to the exchanges and is available on the company's website at https://www.camlinfs.com/investor-relations/home/investorcallrecording. The audio recordings were also uploaded to the stock exchange on August 11, 2026.
- UPSI Compliance: The management explicitly stated that discussions were based on publicly available information and that no unpublished price sensitive information (UPSI) was shared during the call.
Financial Highlights & Guidance from the Call:
- Financial Period Discussed: Q1 FY27 (quarter ended June 30, 2026).
- Revenue: Standalone and Consolidated revenue was INR 5,199 million, a 28% increase Year-over-Year (YoY) and nearly INR 1,000 million higher than the previous quarter (Q4 FY26).
- EBITDA Margin: Dropped significantly to 4% from 45% in the previous quarter. The decline was attributed to a 4-5% gross margin impact from high raw material and freight costs, and a further 1-2% impact from financing costs related to working capital management.
- Segmental Reporting: The company has restructured its reporting into three segments:
- Specialty Ingredients (Blends & Straights): Revenue exceeded INR 4,000 million, with an EBITDA margin of 6.35%. This includes straights sales of INR 927 million and value-added blends sales of over INR 3,000 million.
- Aroma (Vanillin): Sold 560 tons (200 tons Methyl Vanillin, 350 tons Ethyl Vanillin, 10 tons other). The segment reported a negative EBITDA of approximately INR 40-45 million due to low capacity utilization during the ramp-up of a new Ethyl Vanillin campaign. 95% of customers have approved the new Ethyl Vanillin.
- Performance Chemicals: Revenue of INR 175 million (net of large inter-segment transfers) with an EBITDA margin of 2.5%. The segment was negatively impacted by the economic shutdown of the diphenol plant.
- Full-Year Guidance (FY27): Management reiterated its revenue guidance of INR 22,000 - INR 24,000 million. However, EBITDA margin guidance was revised downward to 10-12% from the previous expectation of 12-14%, implying an EBITDA of approximately INR 220 - INR 288 million.
- Q2 FY27 Outlook: Management expects significant improvement in Q2 across all segments. The Aroma segment is forecast to become EBITDA positive, Performance Chemicals is expected to turn positive, and Specialty Ingredients margins are anticipated to improve. Key drivers include a switch to Methyl Vanillin production (500-600 tons expected), resolution of one-time issues in Brazil, and partial passing through of cost increases to customers.
- Capital & Debt: Gross debt stood at INR 6,400 million as of the end of Q1, down from INR 6,700 million at March 31, 2026. To support working capital for growth, the company anticipates needing to secure additional credit lines of INR 1,000 - INR 2,000 million in the coming months.
- Exceptional Item: An exceptional item of approximately INR 400 million was recorded related to a settled insurance claim for a fire that occurred in February in Brazil (the company accepted a 20% haircut for a quicker cash settlement).
Additional Notes Section
- The provided data is the full transcript of the earnings conference call, which was enclosed as an attachment to the regulatory filing.
- The transcript itself contains extensive financial data, performance metrics, and forward-looking guidance as discussed by management during the call.
- The filing and transcript serve as compliance with Regulation 30(6) of the SEBI Listing Regulations.
Tagging: